Ring Christine, CLO, reported a transaction classified as exercise at Nurix Therapeutics, Inc. involving 5537.000000 shares for an estimated $10298.82. Reported holdings after the transaction were 38298.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
Chief Legal Officer
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Represents the weighted average sale price. The lowest price at which shares were sold was $19.465 and the highest price at which shares were sold was $20.42. The Reporting Person undertakes to provid…
The option vested as to 1/4 of the total shares on September 9, 2020, and then 1/48 of the total shares vested monthly thereafter until the option was fully vested on August 9, 2023.
0 other filings
0 recent txs